PFA
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Limited (formerly Sun and Shine Worldwide Limited) reported zero revenue from operations for Q1 FY26, same as Q1 FY25. Total expenses stood at Rs. 5.34 lacs vs Rs. 3.99 lacs in the year-ago quarter, driven mainly by employee costs (Rs. 0.30 lac) and other expenses (Rs. 5.04 lacs). The company posted a net loss of Rs. 5.34 lacs for the quarter, slightly wider than the Rs. 3.99 lac loss in Q1 FY25. There were no exceptional items this quarter, compared to Rs. 17.16 lacs in the prior-year period. Full-year FY25 ended with a net loss of Rs. 58.38 lacs. The statutory auditor (Rishi Sekhri and Associates) issued an unmodified limited review report with no qualifications.
The company continues to generate no operating revenue and is reporting persistent losses, suggesting limited business activity and potential going concern risks for shareholders. The stock is likely illiquid and of speculative nature given the negligible scale of operations.